Recent reports implicate
poly(ADP-ribose) polymerase-1 (PARP-1) in the activation of
nuclear factor kappaB (
NF-kappaB). We investigated the role of PARP-1 in the
NF-kappaB signalling cascade induced by ionizing radiation (IR).
AG14361, a potent PARP-1 inhibitor, was used in two
breast cancer cell lines expressing different levels of constitutively activated
NF-kappaB, as well as mouse embryonic fibroblasts (MEFs) proficient or deficient for PARP-1 or
NF-kappaB p65. In the
breast cancer cell lines,
AG14361 had no effect on IR-induced degradation of
IkappaBalpha or nuclear translocation of p50 or p65. However,
AG14361 inhibited IR-induced
NF-kappaB-dependent transcription of a
luciferase reporter gene. Similarly, in PARP-1(-/-) MEFs, IR-induced nuclear translocation of p50 and p65 was normal, but kappaB binding and transcriptional activation did not occur.
AG14361 sensitized both
breast cancer cell lines to IR-induced cell killing, inhibited IR-induced XIAP expression and increased
caspase-3 activity. However,
AG14361 failed to increase IR-induced
caspase activity when p65 was knocked down by
siRNA. Consistent with this,
AG14361 sensitized p65(+/+) but not p65(-/-) MEFs to IR. We conclude that PARP-1 activity is essential in the upstream regulation of IR-induced
NF-kappaB activation. These data indicate that potentiation of IR-induced cytotoxicity by
AG14361 is mediated solely by inhibition of
NF-kappaB activation.